Научно-практическая ревматология (Nov 2022)

Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis

  • E. S. Kuvardin,
  • D. Yu. Andreev,
  • P. A. Yastrebov,
  • V. Yu. Myachikova,
  • D. V. Bukhanova,
  • D. V. Karpova,
  • K. N. Malikov,
  • M. Yu. Samsonov,
  • A. L. Maslyanskiy

DOI
https://doi.org/10.47360/1995-4484-2022-603-608
Journal volume & issue
Vol. 60, no. 5
pp. 603 – 608

Abstract

Read online

Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosological form. In the paper described clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis with interstitial lung disease, polyserositis, severe microcirculatory alterations.

Keywords